English Spanish Chinese Russian German Japanese Portuguese Hindi Telugu Tamil

Annales de la recherche clinique et de laboratoire

  • ISSN: 2386-5180
  • Indice h du journal: 17
  • Note de citation du journal: 6.26
  • Facteur d’impact du journal: 5.31
Indexé dans
  • Genamics JournalSeek
  • Infrastructure nationale des connaissances en Chine (CNKI)
  • CiteFactor
  • Répertoire d'indexation des revues de recherche (DRJI)
  • Publions
  • Pub européen
  • Google Scholar
  • SHERPA ROMÉO
  • Laboratoires secrets des moteurs de recherche
Voir plus
Partager cette page

Abstrait

Validation of the Reagent Hormone AntiMullerian Plus (Roche Diagnostics) for the Dosage of FSH Recombinant Delta (Ferring Pharmaceuticals) in Patients Submitted to Techniques of Assisted Reproduction

Maria De Las Mercedes Calero Ruiz, Marta Rico Rodriguez, Olga Diz Mellado, Ana Isabel Mangano Armada, Maria Angeles Bailén Garcia and Rafael Torrejon Cardoso

Ovarian stimulation is one of the fundamental pillars on which the treatment of in vitro fertilization is based The biopharmaceutical company Ferring has proposed the posology of recombinant FSH in an individualized manner according to the levels of anti-Mulleriana hormone in blood and body weight